Valeant Pharmaceuticals plunged more than 45% after the once high-flying Canadian biotech company reported earnings, slashed guidance and warned of a potential default. There are many important lessons investors can learn (or relearn) from the collapse in $VRX and I will cover three of them today.
Stocks rallied nicely last week but it was another volatile week. The moves that are occurring in capital markets are wild. In fact, they are some of the largest moves (both up and down) we have seen in years. The wild moves are taking place across several asset classes with some of the largest swings […]
Today, I’m reminded of the old Wall Street adage: Buy The Rumor, Sell The News. On average, capital markets are a forward looking mechanism and tend to discount future events. So they tend to rally into a major event then sell off when the event actually occurs. We have seen tremendous moves in global markets […]
Stocks are mixed after opening weaker on Monday. The Nasdaq/Nasdaq 100 names continue to under-perform while the Russell led for most of the day. Over the last four weeks, stocks have gone from deeply oversold in the short term to deeply over bought. Since the Feb 11 low, the benchmark S&P 500 has surged a very impressive 11%! Remember, […]